About AML Matters

AML Matters is an education program designed to improve the diagnosis and treatment of acute myeloid leukemia (AML). The program is being hosted by the American Society of Hematology, American Society for Clinical Pathology, National Marrow Donor Program, Oncology Nursing Society, and The France Foundation.

AML was diagnosed in approximately 20,000 people in the United States in 2016, and of those patients over half will die from this disease. Recently, there have been significant advances in the diagnosis and management of AML, which warrant ongoing education for the interdisciplinary care team involved in the management of patients with AML.

This educational program will provide guidance to the interdisciplinary AML care team on the optimal diagnosis and classification of AML, risk stratification, and individualized treatment selection, assessment of treatment responses, monitoring for and mitigation of adverse events, and patient education regarding prognosis and treatment choices.

The target audience for this initiative includes hematology/oncology physicians, advance practice professionals, and nurses; hematopathologists/pathologists; HCT clinicians, and other healthcare professionals.

Participants in the program will attend one of four summits held in North America and will actively engage in multidisciplinary, interactive small-group activities, including:

  • a case-based tumor board
  • diagnosing AML
  • treatment decision-making
  • MRD/CR1 and the role of transplants
  • relapsed refractory disease

Steering Committee

Jessica Altman, MD, Chair
Associate Professor of Medicine Hematology/Oncology
Northwestern University
Feinberg School of Medicine
Chicago, Illinois

AnneMarie Block, PhD, FACMG
Laboratory Director, Cytogenetics Lab
Department of Pathology and Laboratory Medicine
Associate Professor of Oncology
Roswell Park Cancer Institute
Buffalo, New York

Linda Burns, MD
Vice President and Medical Director of Health Services Research
National Marrow Donor Program/Be The Match
Minneapolis, Minnesota

Robert Paul Hasserjian, MD
Associate Pathologist
Director, Hematopathology Fellowship Program
Pathology Service
Massachusetts General Hospital
Associate Professor of Pathology
Harvard Medical School
Boston, Massachusetts

Heidi Klepin, MD
Associate Professor
Hematology/Oncology
Wake Forest Baptist Health
Winston Salem, North Carolina

Bruno Medeiros, MD
Associate Professor of Medicine
Hematology
Stanford University Medical Center
Stanford, California

Martin Tallman, MD
Chief, Leukemia Service
Memorial Sloan Kettering Cancer Center
New York, New York

Kathleen Wiley, RN, MSN, AOCNS
Oncology Clinical Specialist
Oncology Nursing Society
Pittsburgh, Pennsylvania

back to top